From: Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways
Gene | RefSeq | Description | Array Fold Change | Q-Value | qPCR Fold Change |
---|---|---|---|---|---|
BCCIP | NM_078469 | BRCA2 and CDKN1A interacting protein | 2.33 | 0.0021 | 1.57 |
BCL2 | NM_000633 | B-cell CLL/lymphoma 2 | -1.47 | 0.0487 | -1.50 |
CCND1 | NM_053056 | Cyclin D1 | 1.51 | 0.0087 | 1.33 |
CDKN1A | NM_000389 | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 1.71 | 0.0001 | 1.98 |
GADD45A | NM_001924 | Growth arrest and DNA-damage-inducible, alpha | 1.92 | 0.0015 | 2.16 |
HERC5 | NM_016323 | Hect domain and RLD 5 | 3.93 | 0.0000 | 2.28 |
MCM5 | NM_006739 | Minichromosome maintenance complex component 5 | -1.58 | 0.0415 | -1.46 |
PPP1R15A | NM_014330 | Protein phosphatase 1, regulatory (inhibitor) subunit 15A | 2.55 | 0.0004 | 2.45 |
SUMO1 | NM_001005781 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 2.00 | 0.0002 | 1.32 |
UBA1 | NM_003334 | Ubiquitin-like modifier activating enzyme 1 | 1.58 | 0.0232 | 1.43 |